{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:07:26Z","timestamp":1792130846030,"version":"4.4.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Anthracyclines, a class of drugs considered as most effective anticancer drugs, used in the various regimens of cancer chemotherapy, induce long-term impairment of mitochondrial respiration, increase reactive oxygen species, and induce other mechanisms potentially leading to neurotoxicity. According to literature findings, one drug of this class - doxorubicin used to treat e.g. breast cancer, bladder cancer, lymphoma, and acute lymphocytic leukemia may induce such effects in the nervous system. Doxorubicin has poor penetration into the brain due to the lack of drug penetration through the blood-brain barrier, thus the toxicity of this agent is the result of its peripheral action. This action is manifested by cognitive impairment and anatomical changes in the brain and peripheral nervous system found in both preclinical and clinical studies in adult patients. Furthermore, more than 50% of children with cancer are treated with anthracyclines including doxorubicin, which may affect their nervous system, and lead to lifelong damage in many areas of their life. Despite ongoing research into the side effects of this drug, the mechanism of its neurotoxicity action on the central and peripheral nervous system is still not well understood. This review aims to summarize the neurotoxic effects of doxorubicin in preclinical (in vitro and in vivo) research and in clinical studies. Furthermore, it discusses the possible mechanisms of the toxic action of this agent on the nervous system.<\/jats:p>","DOI":"10.1007\/s12640-023-00652-5","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T21:29:35Z","timestamp":1687555775000},"page":"383-397","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["A Review on the Neurotoxic Effects of Doxorubicin"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7936-9374","authenticated-orcid":false,"given":"Katarzyna","family":"Kami\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1605-4447","authenticated-orcid":false,"given":"Agnieszka","family":"Cudnoch-J\u0119drzejewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,23]]},"reference":[{"issue":"3","key":"652_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/brainsci10030152","volume":"10","author":"I Alharbi","year":"2020","unstructured":"Alharbi I, Alharbi H, Almogbel Y, Alalwan A, Alhowail A (2020) Effect of Metformin on Doxorubicin-Induced Memory Dysfunction. Brain Sci 10(3):152. https:\/\/doi.org\/10.3390\/brainsci10030152","journal-title":"Brain Sci"},{"issue":"6","key":"652_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/15376516.2019.1600086","volume":"29","author":"AH Alhowail","year":"2019","unstructured":"Alhowail AH, Bloemer J, Majrashi M et al (2019) Doxorubicin-induced neurotoxicity is associated with acute alterations in synaptic plasticity, apoptosis, and lipid peroxidation. Toxicol Mech Methods 29(6):457\u2013466. https:\/\/doi.org\/10.1080\/15376516.2019.1600086","journal-title":"Toxicol Mech Methods"},{"key":"652_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-1-4419-6306-2_19","volume":"678","author":"CD Aluise","year":"2010","unstructured":"Aluise CD, Sultana R, Tangpong J et al (2010) Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative\/nitrosative stress in cognitive dysfunction. Adv Exp Med Biol 678:147\u201356. https:\/\/doi.org\/10.1007\/978-1-4419-6306-2_19","journal-title":"Adv Exp Med Biol"},{"key":"652_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1200\/EDBK_100015","volume":"38","author":"S Armenian","year":"2018","unstructured":"Armenian S, Bhatia S (2018) Predicting and Preventing Anthracycline-Related Cardiotoxicity. Am Soc Clin Oncol Educ Book 38:3\u201312. https:\/\/doi.org\/10.1200\/EDBK_100015","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"652_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.pbb.2014.06.021","volume":"124","author":"S Aziriova","year":"2014","unstructured":"Aziriova S, Bednarova K, Krajcirovicova K et al (2014) Doxorubicin-induced behavioural disturbances in rats: protective effect of melatonin and captopril. Pharmacol Biochem Behav 124:284\u20139. https:\/\/doi.org\/10.1016\/j.pbb.2014.06.021","journal-title":"Pharmacol Biochem Behav"},{"issue":"52","key":"652_CR6","doi-asserted-by":"publisher","first-page":"48921","DOI":"10.1074\/jbc.M108674200","volume":"276","author":"X Bian","year":"2001","unstructured":"Bian X, McAllister LM, Shao F et al (2001) NF-\u03baB activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J. Biol. Chem 276(52):48921\u201348929. https:\/\/doi.org\/10.1074\/jbc.M108674200","journal-title":"J. Biol. Chem"},{"issue":"6","key":"652_CR7","first-page":"1349","volume":"66","author":"RT Bronson","year":"1982","unstructured":"Bronson RT, Henderson IC, Fixler H (1982) Ganglioneuropathy in rabbits and a rhesus monkey due to high cumulative doses of doxorubicin. Cancer Treat Rep 66(6):1349\u201355","journal-title":"Cancer Treat Rep"},{"key":"652_CR8","doi-asserted-by":"publisher","unstructured":"Cavalier AN, Clayton ZS, Hutton DA et al (2021) Accelerated aging of the brain transcriptome by the common chemotherapeutic doxorubicin. Exp Gerontol 152:111451. https:\/\/doi.org\/10.1016\/j.exger.2021.111451","DOI":"10.1016\/j.exger.2021.111451"},{"key":"652_CR9","doi-asserted-by":"publisher","unstructured":"Chaterjee K, Zhang J, Honbo N, Karliner JS (J2010) Doxorubicin Cardiomyopathy. Cardiology. 115(2):155\u2013162.\u00a0https:\/\/doi.org\/10.1159\/000265166.","DOI":"10.1159\/000265166"},{"issue":"6","key":"652_CR10","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1097\/00005072-197711000-00003","volume":"36","author":"ES Cho","year":"1977","unstructured":"Cho ES (1977) Toxic effects of adriamycin on the ganglia of the peripherial nervous system: a neuropathological study. J Neuropathol Exp Neurol 36(6):907\u201315. https:\/\/doi.org\/10.1097\/00005072-197711000-00003","journal-title":"J Neuropathol Exp Neurol"},{"key":"652_CR11","first-page":"583","volume":"1","author":"ES Cho","year":"1980","unstructured":"Cho ES, Spencer PS, Jortner BS, Schaumberg HH (1980) A single intravenous injection of doxorubicin (AdriamycinR) induces sensory neuronopathy in rats. Neurotoxicol 1:583\u2013591","journal-title":"Neurotoxicol"},{"key":"652_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.biocel.2017.03.015","volume":"87","author":"J Chwastek","year":"2017","unstructured":"Chwastek J, Jantas D, Laso\u0144 W (2017) The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell damage via a \u03b3H2AX\/p-p53\/caspase-3-independent mechanism: Inhibition of calpain and cathepsin D. Int J Biochem Cell Biol 87:38\u201353. https:\/\/doi.org\/10.1016\/j.biocel.2017.03.015","journal-title":"Int J Biochem Cell Biol"},{"issue":"16","key":"652_CR13","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1002\/cncr.25362","volume":"116","author":"M Cianfrocca","year":"2010","unstructured":"Cianfrocca M, Lee S, Von Roenn J et al (2010) Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy. Cancer 116(16):3969\u201377. https:\/\/doi.org\/10.1002\/cncr.25362","journal-title":"Cancer"},{"issue":"2","key":"652_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.breast.2013.01.015","volume":"22","author":"D Crivellari","year":"2013","unstructured":"Crivellari D, Gray KP, Dellapasqua, et al (2013) Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a \u201cstandard chemotherapy regimen\u201d: the CASA randomized trial. Breast 22(2):130\u2013137. https:\/\/doi.org\/10.1016\/j.breast.2013.01.015","journal-title":"Breast"},{"issue":"31","key":"652_CR15","doi-asserted-by":"publisher","first-page":"8051","DOI":"10.1016\/j.biomaterials.2010.06.054","volume":"31","author":"M Dadsetan","year":"2010","unstructured":"Dadsetan M, Liu Z, Pumberger M et al (2010) stimuli-responsive hydrogel for doxorubicin delivery. Biomaterials 31(31):8051\u201362. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.06.054","journal-title":"Biomaterials"},{"issue":"2","key":"652_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1046\/j.1471-4159.2000.0750532.x","volume":"75","author":"S Di Bartolomeo","year":"2000","unstructured":"Di Bartolomeo S, Di Sano F, Piacentini M, Spinedi A (2000) Apoptosis induced by doxorubicin in neurotumor cells is divorced from drug effects on ceramide accumulation and may involve cell cycle-dependent caspase activation. J Neurochem 75(2):532\u2013539. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0750532.x","journal-title":"J Neurochem"},{"key":"652_CR17","unstructured":"Douedi S, Carson MP (2021) Anthracycline Medications (Doxorubicin). In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing; 2022"},{"key":"652_CR18","doi-asserted-by":"publisher","unstructured":"Du J, Zhang A, Li J et al (2021) Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights. Front Oncol 13:11:673340. https:\/\/doi.org\/10.3389\/fonc.2021.673340.","DOI":"10.3389\/fonc.2021.673340"},{"key":"652_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0014-4886(82)90245-X","volume":"77","author":"EL Eddy","year":"1982","unstructured":"Eddy EL, Nathaniel EJH (1982) An ultrastructural study of the effects of adriamycin on the dorsal root ganglia of young and adult rats. Exp Neural 77:275\u2013285","journal-title":"Exp Neural"},{"issue":"1","key":"652_CR20","first-page":"83","volume":"153","author":"EL Eddy","year":"1983","unstructured":"Eddy EL (1983) Neuronal loss from cervical dorsal root ganglia in adriamycin induced peripheral neuropathy\u2013a quantitative study. Anat Anz 153(1):83\u201390","journal-title":"Anat Anz"},{"key":"652_CR21","doi-asserted-by":"publisher","unstructured":"Eide S, Feng ZP (2020) Doxorubicin chemotherapy-induced \"chemo-brain\": Meta-analysis. Eur J Pharmacol 881:173078. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173078.","DOI":"10.1016\/j.ejphar.2020.173078"},{"key":"652_CR22","doi-asserted-by":"publisher","unstructured":"El-Agamy SE, Abdel-Aziz AK, Wahdan S et al (2018) Astaxanthin ameliorates doxorubicin-induced cognitive impairment (chemobrain) ine rat model: Impact on oxidative, inflammatory, and apoptotic machineries. Mol Neurobiol 55:5727\u20135740.\u00a0https:\/\/doi.org\/10.1007\/s12035-017-0797-7","DOI":"10.1007\/s12035-017-0797-7"},{"issue":"1","key":"652_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00280-019-03827-0","volume":"84","author":"SE El-Agamy","year":"2019","unstructured":"El-Agamy SE, Abdel-Aziz AK, Esmat A, Azab SS (2019) Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain. Cancer Chemother Pharmacol 84(1):1\u201314. https:\/\/doi.org\/10.1007\/s00280-019-03827-0","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"652_CR24","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/toxsci\/kfx267","volume":"162","author":"TJ Flanigan","year":"2018","unstructured":"Flanigan TJ, Anderson JE, Elayan I, Anti~no RA, Ferguson SA, (2018) Effects of Cyclophosphamide and\/or doxorubicin in a murine model of postchemotherapy Cc ognitive impairment. Toxicol Sci 162(2):462\u2013474. https:\/\/doi.org\/10.1093\/toxsci\/kfx267","journal-title":"Toxicol Sci"},{"issue":"4","key":"652_CR25","first-page":"649","volume":"45","author":"FA Fornari","year":"1994","unstructured":"Fornari FA, Randolph JK, Yalowich JC, Ritke MK, Gewirtz DA (1994) Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol Pharmacol 45(4):649\u201356","journal-title":"Mol Pharmacol"},{"issue":"10","key":"652_CR26","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1021\/bi00462a016","volume":"29","author":"CA Frederick","year":"1990","unstructured":"Frederick CA, Williams LD, Ughetto G et al (1990) Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin. Biochem 29(10):2538\u201349. https:\/\/doi.org\/10.1021\/bi00462a016","journal-title":"Biochem"},{"issue":"Suppl 3","key":"652_CR27","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.3816\/cbc.2002.s.019","volume":"3","author":"JR Freeman","year":"2002","unstructured":"Freeman JR, Broshek DK (2002) Assessing cognitive dysfunction in breast cancer: what are the tools? Clin Breast Cancer. 3(Suppl 3):S91-9. https:\/\/doi.org\/10.3816\/cbc.2002.s.019. PMID: 12533269","journal-title":"Clin Breast Cancer."},{"issue":"6","key":"652_CR28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1054\/ghir.1999.0130","volume":"9","author":"I Gil-Ad","year":"1999","unstructured":"Gil-Ad I, Shtaif B, Luria D et al (1999) Insulin-like-growth-factor-I (IGF-I) antagonizes apoptosis induced by serum deficiency and doxorubicin in neuronal cell culture. Growth Horm IGF Res 9(6):458\u201364. https:\/\/doi.org\/10.1054\/ghir.1999.0130","journal-title":"Growth Horm IGF Res"},{"issue":"17","key":"652_CR29","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1200\/JCO.2000.18.17.3093","volume":"18","author":"AN Gordon","year":"2000","unstructured":"Gordon AN, Granai CO, Rose PG et al (2000) Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer. J Clin Oncol 18(17):3093\u2013100. https:\/\/doi.org\/10.1200\/JCO.2000.18.17.3093","journal-title":"J Clin Oncol"},{"issue":"11","key":"652_CR30","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1080\/10715760500143478","volume":"39","author":"J Gururaj","year":"2005","unstructured":"Gururaj J, Rukhsana S, Jitbanjong T et al (2005) Free radical mediated oxidative stress and toxic side effects in brain induced by the anticancer drug adriamycin: Insight into chemobrain. Free Rad Rese 39(11):1147\u20131154. https:\/\/doi.org\/10.1080\/10715760500143478","journal-title":"Free Rad Rese"},{"issue":"18","key":"652_CR31","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1001\/jama.1994.03520180051034","volume":"272","author":"R Haupt","year":"1994","unstructured":"Haupt R, Fears TR, Robison LL et al (1994) Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. JAMA 272(18):1427\u20131432","journal-title":"JAMA"},{"key":"652_CR32","doi-asserted-by":"publisher","unstructured":"Imosemi IO, Owumi SE, Arunsi UO (2022) Biochemical and histological alterations of doxorubicin\u2010induced neurotoxicity in rats: protective role of luteolin. J Biochem Mol Toxicol 36:e22962. https:\/\/doi.org\/10.1002\/jbt.22962","DOI":"10.1002\/jbt.22962"},{"key":"652_CR33","doi-asserted-by":"publisher","unstructured":"Jantas D, Pytel M, Mozrzymas JW et al (2008) The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem Int 52(4\u20135):864\u201377. https:\/\/doi.org\/10.1016\/j.neuint.2007.10.003.","DOI":"10.1016\/j.neuint.2007.10.003"},{"issue":"1","key":"652_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12640-009-9002-8","volume":"15","author":"D Jantas","year":"2009","unstructured":"Jantas D, Lason W (2009) Protective effect of memantine against Doxorubicin toxicity in primary neuronal cell cultures: influence a development stage. Neurotox Res 15(1):24\u201337. https:\/\/doi.org\/10.1007\/s12640-009-9002-8","journal-title":"Neurotox Res"},{"issue":"2","key":"652_CR35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s12640-013-9430-3","volume":"25","author":"D Jantas","year":"2014","unstructured":"Jantas D, Krawczyk S, Lason W (2014) The predominant protective effect of tianeptine over other antidepressants in models of neuronal apoptosis: the effect blocked by inhibitors of MAPK\/ERK1\/2 and PI3-K\/Akt pathways. Neurotox Res 25(2):208\u201325. https:\/\/doi.org\/10.1007\/s12640-013-9430-3","journal-title":"Neurotox Res"},{"key":"652_CR36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neuint.2014.12.011","volume":"88","author":"D Jantas","year":"2015","unstructured":"Jantas D, Greda A, Leskiewicz M et al (2015) Neuroprotective effects of mGluR II and III activators against staurosporine- and doxorubicin-induced cellular injury in SH-SY5Y cells: New evidence for a mechanism involving inhibition of AIF translocation. Neurochem Int 88:124\u201337. https:\/\/doi.org\/10.1016\/j.neuint.2014.12.011","journal-title":"Neurochem Int"},{"issue":"4","key":"652_CR37","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/bcpt.13041","volume":"123","author":"D Jantas","year":"2018","unstructured":"Jantas D, Grygier B, Zatorska J, Laso\u0144 W (2018a) Allosteric and Orthosteric Activators of mGluR8 Differentially Affect the Chemotherapeutic-Induced Human Neuroblastoma SH-SY5Y Cell Damage: The Impact of Cell Differentiation State. Basic Clin Pharmacol Toxicol 123(4):443\u2013451. https:\/\/doi.org\/10.1111\/bcpt.13041","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"652_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.neuropharm.2018.08.035","volume":"141","author":"D Jantas","year":"2018","unstructured":"Jantas D, Lech T, Go\u0142da S, Pilc A, Laso\u0144 W (2018b) New evidences for a role of mGluR7 in astrocyte survival: Possible implications for neuroprotection. Neuropharmacology 141:223\u2013237. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.08.035","journal-title":"Neuropharmacology"},{"key":"652_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fphys.2013.00076","volume":"4","author":"S Javadov","year":"2013","unstructured":"Javadov S, Kuznetsov A (2013) Mitochondrial permeability transition and cell death: The role of cyclophilin D. Front Physiol 4:76. https:\/\/doi.org\/10.3389\/fphys.2013.00076","journal-title":"Front Physiol"},{"issue":"11","key":"652_CR40","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1080\/10715760500143478","volume":"39","author":"G Joshi","year":"2005","unstructured":"Joshi G, Sultana R, Tangpong J et al (2005) Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain. Free Radic Res 39(11):1147\u201354. https:\/\/doi.org\/10.1080\/10715760500143478","journal-title":"Free Radic Res"},{"issue":"1","key":"652_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11060-016-2078-0","volume":"128","author":"C Kamiya-Matsuoka","year":"2016","unstructured":"Kamiya-Matsuoka C, Paker AM, Chi L et al (2016) Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study. J Neuro-Oncol 128(1):75\u201384","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"652_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/jamaoncol.2015.4333","volume":"22","author":"SR Kesler","year":"2016","unstructured":"Kesler SR, Blayney DW (2016) Neurotoxic effects of anthracycline- vs nonanthracycline-based chemotherapy on cognition in breast cancer survivors. JAMA Oncol 22(2):185\u201392. https:\/\/doi.org\/10.1001\/jamaoncol.2015.4333","journal-title":"JAMA Oncol"},{"issue":"3","key":"652_CR43","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/pbc.25790","volume":"63","author":"RB Khan","year":"2016","unstructured":"Khan RB, Sadighi ZS, Zabrowski J et al (2016) Imaging patterns and outcome of posterior reversible encephalopathy syndrome during childhood cancer treatment. Pediatr Blood Cancer 63(3):523\u2013526. https:\/\/doi.org\/10.1002\/pbc.25790","journal-title":"Pediatr Blood Cancer"},{"key":"652_CR44","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bbr.2015.06.007","volume":"292","author":"Y Kitamuraa","year":"2015","unstructured":"Kitamuraa Y, Hattoria S, Yonedaa S et al (2015) Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: Possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation. Behav Brain Res 292:184\u2013193. https:\/\/doi.org\/10.1016\/j.bbr.2015.06.007","journal-title":"Behav Brain Res"},{"key":"652_CR45","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.biopha.2018.06.161","volume":"106","author":"F Kuzu","year":"2018","unstructured":"Kuzu F, Kandemir S, Yildirim S et al (2018) Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis. Biomed Pharmacother 106:443\u2013453. https:\/\/doi.org\/10.1016\/j.biopha.2018.06.161","journal-title":"Biomed Pharmacother"},{"key":"652_CR46","doi-asserted-by":"publisher","unstructured":"Lederman HM, Grassi DC, Camargo MV et al (2017) Case report: methrotexate induced neurotoxicity mimicking stroke, following leukoencephalopathy. Int J Radiol Radiat Ther 3(3):237\u2013239. https:\/\/doi.org\/10.15406\/ijrrt.2017.03.00064","DOI":"10.15406\/ijrrt.2017.03.00064"},{"key":"652_CR47","doi-asserted-by":"publisher","unstructured":"Liao D, Xiang D, Dang R et al (2018) Neuroprotective Effects of dl-3-n-Butylphthalide against doxorubicin-induced neuroinflammation, oxidative stress, endoplasmic reticulum stress, and behavioral changes. Oxid Med Cell Longev 9125601. https:\/\/doi.org\/10.1155\/2018\/9125601","DOI":"10.1155\/2018\/9125601"},{"key":"652_CR48","doi-asserted-by":"publisher","unstructured":"Licht T, Sasson E, Bell B et al (2020) Hippocampal neural stem cells facilitate access from circulation via apical cytoplasmic processes. Elife 9:e52134. https:\/\/doi.org\/10.7554\/eLife.52134","DOI":"10.7554\/eLife.52134"},{"issue":"12","key":"652_CR49","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/annonc\/mdp263","volume":"20","author":"C Liedtke","year":"2009","unstructured":"Liedtke C, Broglio K, Moulder S et al (2009) Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer. Ann Oncol 20(12):1953\u20138. https:\/\/doi.org\/10.1093\/annonc\/mdp263","journal-title":"Ann Oncol"},{"key":"652_CR50","doi-asserted-by":"publisher","first-page":"6945415","DOI":"10.1155\/2016\/6945415","volume":"2016","author":"I Lim","year":"2016","unstructured":"Lim I, Joung HY, Yu AR, Shim I, Kim JS (2016) Pet evidence of the effect of donepezil on cognitive performance in an animal model of chemobrain. BioMed Res Int 2016:6945415. https:\/\/doi.org\/10.1155\/2016\/6945415","journal-title":"BioMed Res Int"},{"key":"652_CR51","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.virusres.2018.06.008","volume":"253","author":"YJ Lee","year":"2018","unstructured":"Lee YJ, Lee C (2018) Porcine deltacoronavirus induces caspase-dependent apoptosis through activation of the cytochrome C-mediated intrinsic mitochondrial pathway. Virus Res 253:112\u201323. https:\/\/doi.org\/10.1016\/j.virusres.2018.06.008","journal-title":"Virus Res"},{"key":"652_CR52","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3171\/jns.1991.75.4.0559","volume":"75","author":"BC Liang","year":"1991","unstructured":"Liang BC, Thornton AF Jr, Sandler HM et al (1991) Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy. J Neurosurg. 75:559\u2013563","journal-title":"J Neurosurg."},{"key":"652_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.freeradbiomed.2020.07.018","volume":"160","author":"WS Leung","year":"2020","unstructured":"Leung WS, Kuo WW, Ju DT et al (2020) Protective effects of diallyl trisulfide (DATS) against doxorubicin-induced inflammation and oxidative stress in the brain of rats. Free Radic Biol. 160:141\u2013148. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.07.018","journal-title":"Free Radic Biol."},{"issue":"2","key":"652_CR54","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.neuro.2007.12.003","volume":"29","author":"MA Lopes","year":"2008","unstructured":"Lopes MA, Meisel A, Dirnagl U, Carvalho FD, Bastos Mde L (2008) Doxorubicin induces biphasic neurotoxicity to rat cortical neurons. Neurotox 29(2):286\u201393. https:\/\/doi.org\/10.1016\/j.neuro.2007.12.003","journal-title":"Neurotox"},{"key":"652_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pneurobio.2005.04.006","volume":"76","author":"W L\u00f6scher","year":"2005","unstructured":"L\u00f6scher W, Potschka H (2005) Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog Neurobiol 76:22\u201376. https:\/\/doi.org\/10.1016\/j.pneurobio.2005.04.006","journal-title":"Prog Neurobiol"},{"key":"652_CR56","doi-asserted-by":"publisher","unstructured":"Manal AI, Al-Geam A, Al-Shawi N (2018) Effects of Vitamin E and Q10 Supplementation against Doxorubicin-Induced Neurotoxicity in rats. J Pharm Sci 27(2) . https:\/\/doi.org\/10.31351\/vol27iss2pp24-3124","DOI":"10.31351\/vol27iss2pp24-3124"},{"issue":"2","key":"652_CR57","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11065-017-9365-1","volume":"28","author":"HA Marusak","year":"2018","unstructured":"Marusak HA, Iadipaolo AS, Harper FW et al (2018) Neurodevelopmental consequences of pediatric cancer and its treatment: applying an early adversity framework to understanding cognitive, behavioral, and emotional outcomes. Neuropsychol Rev 28(2):123\u2013175","journal-title":"Neuropsychol Rev"},{"key":"652_CR58","doi-asserted-by":"publisher","unstructured":"Moruno-Manchon JF, Ndidi\u2010Ese U, Kesler SR (2016) TFEB ameliorates the impairment of the autophagy\u2010lysosome pathway in neurons induced by doxorubicin. Aging (Albany NY) 8(12):3507\u20133519. https:\/\/doi.org\/10.18632\/aging.101144.","DOI":"10.18632\/aging.101144"},{"key":"652_CR59","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0041-008X(78)90298-3","volume":"44","author":"M Merker","year":"1978","unstructured":"Merker M, Michael RL, Walker D, Richardson EP Jr (1978) Neurotoxicity of adriamycin (Doxorubicin) perfused through the cerebrospinal fluid spaces of the rhesus monkey. Toxicol Ap Pharmacol 44:191\u2013205","journal-title":"Toxicol Ap Pharmacol"},{"issue":"1","key":"652_CR60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1023\/a:1006342423175","volume":"45","author":"DS Middlemas","year":"1999","unstructured":"Middlemas DS, Kihl BK, Moody NM (1999) Brain derived neurotrophic factor protects human neuroblastoma cells from DNA damaging agents. J Neurooncol 45(1):27\u201336. https:\/\/doi.org\/10.1023\/a:1006342423175","journal-title":"J Neurooncol"},{"issue":"2","key":"652_CR61","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"G Minotti","year":"2004","unstructured":"Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56(2):185\u2013229. https:\/\/doi.org\/10.1124\/pr.56.2.6","journal-title":"Pharmacol Rev"},{"key":"652_CR62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brainresbull.2011.07.001","volume":"86","author":"RH Mohamed","year":"2011","unstructured":"Mohamed RH, Karam KA, Amer MG (2011) Epicatechin attenuates doxorubicin-induced brain toxicity: Critical role of TNF-iNOS and NF-B. Brain Res Bull 86:22\u201328. https:\/\/doi.org\/10.1016\/j.brainresbull.2011.07.001","journal-title":"Brain Res Bull"},{"key":"652_CR63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.32527\/2019\/101396","volume":"9","author":"WI Mohammed","year":"2019","unstructured":"Mohammed WI, Radwan RA, Elsayed HM (2019) Prophylactic and Ameliorative Effect of N-Acetylcysteine on Doxorubicin- Induced Neurotoxicity in Wister Rats. Egypt J Basic Clin Pharmacol 9:16. https:\/\/doi.org\/10.32527\/2019\/101396","journal-title":"Egypt J Basic Clin Pharmacol"},{"key":"652_CR64","doi-asserted-by":"publisher","unstructured":"Mo\u2019mena AA, El Kiki HA, Madney Y, Youssef AA (2021) Chemotherapy\u2011related neurotoxicity in pediatric cancer patients: magnetic resonance imaging and clinical correlation Egypt J Radiol Nucl Med 52:230.\u00a0https:\/\/doi.org\/10.1186\/s43055-021-00606-x","DOI":"10.1186\/s43055-021-00606-x"},{"key":"652_CR65","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.rvsc.2021.09.009","volume":"140","author":"RL Moretti","year":"2021","unstructured":"Moretti RL, Dias EN, Kiel SG et al (2021) Behavioral and morphological effects of resveratrol and curcumin in rats submitted to doxorubicin-induced cognitive impairment. Res in Vet Sci 140:242\u2013250. https:\/\/doi.org\/10.1016\/j.rvsc.2021.09.009","journal-title":"Res in Vet Sci"},{"issue":"1","key":"652_CR66","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1023\/a:1026234130830","volume":"65","author":"LL Muldoon","year":"2003","unstructured":"Muldoon LL, Neuwelt EA (2003) BR96-DOX immunoconjugate targeting of chemotherapy in brain tumor models. J Neurooncol. 65(1):49\u201362. https:\/\/doi.org\/10.1023\/a:1026234130830","journal-title":"J Neurooncol."},{"key":"652_CR67","doi-asserted-by":"publisher","first-page":"11292","DOI":"10.1038\/s41598-020-68017-y","volume":"10","author":"M Norouzi","year":"2020","unstructured":"Norouzi M, Yathindranath V, Thliveris JA et al (2020) Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles. Sci Rep 10:11292. https:\/\/doi.org\/10.1038\/s41598-020-68017-y","journal-title":"Sci Rep"},{"issue":"5","key":"652_CR68","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/ncomms2921","volume":"4","author":"B Pang","year":"2013","unstructured":"Pang B, Qiao X, Janssen L, l. (2013) Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin. Nat Commun 4(5):1908. https:\/\/doi.org\/10.1038\/ncomms2921","journal-title":"Nat Commun"},{"key":"652_CR69","doi-asserted-by":"publisher","unstructured":"Park HS, Kim CJ, Kwak HB et al (2018) Physical exercise\u00a0prevents cognitive impairment by enhancing hippocampal neuroplasticity and\u00a0mitochondrial function in doxorubicin-Iinduced chemobrain. Neuropharmacol 133:451\u201361. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.02.013","DOI":"10.1016\/j.neuropharm.2018.02.013"},{"key":"652_CR70","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbr.2016.04.017","volume":"307","author":"RM Philpot","year":"2016","unstructured":"Philpot RM, Ficken M, Wecker L (2016) Doxorubicin and cyclophosphamide lead to long-lasting impairment of spatial memory in female, but not male mice. Behav Brain Res 307:165\u2013175. https:\/\/doi.org\/10.1016\/j.bbr.2016.04.017","journal-title":"Behav Brain Res"},{"key":"652_CR71","first-page":"347","volume":"12","author":"M Petrovic","year":"2015","unstructured":"Petrovic M, Simillion C, Kruzliank P, Sabo J, Heller M (2015) Doxorubicin Affects Expression of Proteins of Neuronal Pathways in MCF-7 Breast Cancer Cells. CGP 12:347\u2013358","journal-title":"CGP"},{"issue":"53","key":"652_CR72","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/newbio235017a0.PMID4502404","volume":"235","author":"WJ Pigram","year":"1972","unstructured":"Pigram WJ, Fuller W, Hamilton LD (1972) Stereochemistry of intercalation: interaction of daunomycin with DNA. Nat New Biol 235(53):17\u20139. https:\/\/doi.org\/10.1038\/newbio235017a0.PMID4502404","journal-title":"Nat New Biol"},{"issue":"2","key":"652_CR73","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3892\/ijo.2016.3558","volume":"49","author":"N Pilco-Ferreto","year":"2016","unstructured":"Pilco-Ferreto N, Calaf GM (2016) Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines. Int J Oncol 49(2):753\u201362. https:\/\/doi.org\/10.3892\/ijo.2016.3558","journal-title":"Int J Oncol"},{"issue":"5","key":"652_CR74","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","volume":"17","author":"Y Pommier","year":"2010","unstructured":"Pommier Y, Leo E, Zhang H, Marchand C (2010) DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 17(5):421\u201333. https:\/\/doi.org\/10.1016\/j.chembiol.2010.04.012","journal-title":"Chem Biol"},{"key":"652_CR75","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.2147\/DDDT.S103511","volume":"11","author":"GV Ramalingayya","year":"2017","unstructured":"Ramalingayya GV, Cheruku SP, Nayak PG et al (2017) Rutin protects against neuronal damage in vitro and ameliorates doxorubicin-induced memory deficits in vivo in wistar rats. Drug Des Devel Ther 11:1011\u201326a. https:\/\/doi.org\/10.2147\/DDDT.S103511","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"652_CR76","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1615\/JEnvironPatholToxicolOncol.2017017087","volume":"36","author":"G Ramalingayya","year":"2017","unstructured":"Ramalingayya G, Sonawane V, Cheruku SP (2017b) Insulin protects against brain Oxidative stress with an apparent effect on episodic memory in doxorubicin- induced cognitive dysfunction in wistar rats. J Environ Pathol Toxicol Oncol 36(2):121\u2013130. https:\/\/doi.org\/10.1615\/JEnvironPatholToxicolOncol.2017017087","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"652_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2018.12.029","volume":"134","author":"X Ren","year":"2019","unstructured":"Ren X, Keeney JTR, Miriyala S et al (2019) The Triangle of Death of Neurons: Oxidative Damage, Mitochondrial Dysfunction, and Loss of Choline-Containing Biomolecules in Brains of Mice Treated with Doxorubicin. Advanced Insights Into Mechanisms of Chemotherapy Induced Cognitive Impairment (\u201cChemobrain\u201d) Involving TNF-a. Free Radic Biol Med 134:1\u20138. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.12.029","journal-title":"Free Radic Biol Med"},{"key":"652_CR78","doi-asserted-by":"publisher","unstructured":"Rizk HA, Masoud MA, Maher OW (2017) Prophylactic effects of ellagic acid and rosmarinic acid on doxorubicin-induced neurotoxicity in rats. J Biochem Mol Toxicol 31(12). https:\/\/doi.org\/10.1002\/jbt.21977","DOI":"10.1002\/jbt.21977"},{"key":"652_CR79","unstructured":"Rossi S (2013) Australian Medicines Handbook. Adelaide: The Australian Medicines Handbook Unit Trust"},{"issue":"4","key":"652_CR80","first-page":"424","volume":"3","author":"I Sardi","year":"2013","unstructured":"Sardi I, la Marca G, Cardellicchio S et al (2013) Pharmacological Modulation of Blood-Brain Barrier Increases Permeability of Doxorubicin into the Rat Brain. Am J Cancer Res 3(4):424\u201332","journal-title":"Am J Cancer Res"},{"key":"652_CR81","doi-asserted-by":"publisher","unstructured":"Shavali S, Ren J, Ebadi, M (2003) Insulin-like growth factor-1 protects\u00a0human dopaminergic SH-SY5Y cells from salsolinol-induced toxicity.\u00a0Neurosci Lett 340(2):79\u201382. \nhttps:\/\/doi.org\/10.1016\/s0304-3940(02)01461-1","DOI":"10.1016\/s0304-3940(02)01461-1"},{"key":"652_CR82","doi-asserted-by":"publisher","unstructured":"Shokoohinia Y, Hosseinzadeh L, Moieni-Arya M, Mostafaie A, Mohammadi-Motlagh HR (2014) Osthole Attenuates Doxorubicin-Induced Apoptosis in PC12\u00a0Cells Through Inhibition of Mitochondrial Dysfunction and ROS Production.\u00a0BioMed Res 156848. \nhttps:\/\/doi.org\/10.1155\/2014\/156848","DOI":"10.1155\/2014\/156848"},{"issue":"1","key":"652_CR83","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","volume":"61","author":"T Sim\u016fnek","year":"2009","unstructured":"Sim\u016fnek T, St\u00e9rba M, Popelov\u00e1 O, Adamcov\u00e1 M, Hrdina R, Gersl V (2009) Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron\". Pharmacol Rep 61(1):154\u201371. https:\/\/doi.org\/10.1016\/S1734-1140(09)70018-0","journal-title":"Pharmacol Rep"},{"issue":"2","key":"652_CR84","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","volume":"65","author":"O Tacar","year":"2013","unstructured":"Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65(2):157\u201370. https:\/\/doi.org\/10.1111\/j.2042-7158.2012.01567.x","journal-title":"J Pharm Pharmacol"},{"key":"652_CR85","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.pcad.2006.10.002","volume":"49","author":"G Takemura","year":"2007","unstructured":"Takemura G, Fujiwara H (2007) The Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis 49:330\u2013352","journal-title":"Prog Cardiovasc Dis"},{"key":"652_CR86","doi-asserted-by":"crossref","unstructured":"Tangpong J, Cole MP, Sultana R (2006) Adriamycin-induced, TNF-mediated central nervous system toxicity. Neurobiol Dis 23:127\u2013139.","DOI":"10.1016\/j.nbd.2006.02.013"},{"issue":"1","key":"652_CR87","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1471-4159.2006.04179.x","volume":"100","author":"J Tangpong","year":"2007","unstructured":"Tangpong J, Cole MP, Sultana R et al (2007) Doxorubicin-mediated nitration of manganese superoxide dismutase in the central nervous system: Insight into the mechanism of chemobrain. J Neurochem 100(1):191\u2013201. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04179.x","journal-title":"J Neurochem"},{"issue":"1","key":"652_CR88","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/nano9010096","volume":"9","author":"DM Teleanu","year":"2019","unstructured":"Teleanu DM, Chircov C, Grumezescu AM, Teleanu RI (2019) Neurotoxicity of Nanomaterials: An Up-to-Date Overview. Nanomaterials (Basel) 9(1):96. https:\/\/doi.org\/10.3390\/nano9010096","journal-title":"Nanomaterials (Basel)"},{"issue":"10","key":"652_CR89","doi-asserted-by":"publisher","first-page":"949","DOI":"10.2147\/IJN.S72590","volume":"29","author":"K Tomankova","year":"2015","unstructured":"Tomankova K, Polakova K, Pizova K et al (2015) In vitro cytotoxicity analysis of doxorubicin-loaded\/superparamagnetic iron oxide colloidal nanoassemblies on MCF7 and NIH3T3 cell lines. Int J Nanomedicine 29(10):949\u201361. https:\/\/doi.org\/10.2147\/IJN.S72590","journal-title":"Int J Nanomedicine"},{"key":"652_CR90","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","volume":"01","author":"DD Von Hoff","year":"1979","unstructured":"Von Hoff DD, Layard MW, Basa P et al (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 01:710\u2013717","journal-title":"Ann Intern Med"},{"issue":"6","key":"652_CR91","first-page":"670","volume":"19","author":"RB Weiss","year":"1992","unstructured":"Weiss RB (1992) The anthracyclines: will we ever find a better doxorubicin?\". Seminars in Oncol 19(6):670\u201386","journal-title":"Seminars in Oncol"},{"key":"652_CR92","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.3969\/j.issn.1673-5374.2013.17.009","volume":"8","author":"M Yang","year":"2013","unstructured":"Yang M, Moon C (2013) Neurotoxicity of cancer chemotherapy. Neural Regen Res 8:1606\u20131614. https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2013.17.009","journal-title":"Neural Regen Res"},{"issue":"3","key":"652_CR93","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov DB, Juhaszova M, Sollott SJ (2014) Mitochondrial Reactive Oxygen Species (ROS) and ROS-induced ROS Release. Physiol Rev 94(3):909\u201350. https:\/\/doi.org\/10.1152\/physrev.00026.2013","journal-title":"Physiol Rev"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-023-00652-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-023-00652-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-023-00652-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T08:12:45Z","timestamp":1694592765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-023-00652-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,23]]},"references-count":93,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1007\/s12640-023-00652-5","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,23]]},"assertion":[{"value":"4 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}